| Refine your search: | Drug Interactions |
|
Aplenzin
The United States Food and Drug Administration (FDA) has approved Aplenzin (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide for the treatment of depression in adults. Aplenzin is an alcohol-resistant formulation of a new bupropion salt and has been approved in 174mg,...
Consumer Information (Drugs.com) · More like this · Add to my drug list
Aplenzin Extended-Release Tablets
Aplenzin is used for: Treating depression. It may also be used for other conditions as determined by your doctor.
Consumer Information (MedFacts) · More like this · Add to my drug list
Aplenzin
Advanced Consumer Information (Micromedex) · More like this · Add to my drug list
Aplenzin (Bupropion)
Exact mechanism of antidepressant or smoking deterrent activity is unknown, but it is presumed to be mediated by noradrenergic and/or dopaminergic mechanisms.
A-Z Drug Facts (Facts & Comparisons) · More like this · Add to my drug list
Biovail Receives FDA Approval for Aplenzin (BVF-033)
...announced today that it has received Approval from the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for Aplenzin (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide developed by Biovail for the treatment of depression in adults....
New Drug Approvals (FDA) · More like this
See also: Bipolar Disorder, Depression, Migraine Prevention, Obesity, Panic Disorder, Premenstrual Dysphoric Disorder
Having trouble finding what you want?
- Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
- Try posting your query on the Drugs.com Community Discussion Boards
- Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
- Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
- Image Search is helpful if you want to know what a certain pill looks like.
- News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.
